Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1164 of 5804
-
New pill could help shed pounds without needles
Disease control Recruiting nowThe aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral ecnoglutide tablets in Chinese participants with overweight or obesity
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New nanoparticle imaging trial aims to light up hidden tumors
Diagnosis Recruiting nowThis is an open-label, first-in-human, dose escalation study evaluating investigational drug PORPHYSOSMES (PS, pegylated porphyrin-lipid conjugate-containing nanoparticle suspension) and 64Cu-PORPHYSOMES (64Cu-PS, pegylated Copper-64 labelled porphyrin-lipid conjugate-containing …
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
At-Home brain zaps show promise for depression relief
Symptom relief Recruiting nowDepression is a prevalent and debilitating disorder. The most common treatments are antidepressant medications and talking therapies. However, for many individuals, these are not their treatment of choice. Furthermore, even following a full course of treatment with an antidepress…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Can ChatGPT spot cancer cells as well as a pathologist?
Diagnosis OngoingThe aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretatio…
Sponsor: Orlando Health, Inc. • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New combo therapy aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowBrief Summary: The purpose of this clinical trial is to evaluate the safety, tolerability, preliminary efficacy, and immunogenicity of EVM14 administered intramuscularly (IM) alone and in combination with pembrolizumab in patients with selected solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
AI eye test could catch glaucoma early in diabetics
Diagnosis Recruiting nowGlaucoma is major cause of irreversible blindness and is characterized by optic nerve damage and visual field loss. Screening for glaucoma is challenging due to lack of a simple, accurate, cost-efficient and standardized process. Artificial intelligence, (AI) especially deep lear…
Phase: NA • Sponsor: Singapore Eye Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Magnetic pulses to the brain may lift long COVID fog
Symptom relief Recruiting nowCognitive problems and severe fatigue are two frequently occurring symptoms in long COVID, also known as Post-Covid Condition or Post-Acute Sequelae of COVID-19 (PASC), and their causes are currently unknown. Previous studies have shown reduced blood flow and increased inflammati…
Phase: NA • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New ultrasound test could make liver fat detection quick and painless
Diagnosis Recruiting nowThe research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD). Current tests, like MRI or b…
Phase: NA • Sponsor: ContextVision AB • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New hope for myelofibrosis: experimental combo targets Drug-Resistant patients
Disease control Recruiting nowThe goal of this clinical trial is to learn how roginolisib works in comparison to standard treatment in adult patients with Myelofibrosis. The main questions it aims to answer is to evaluate the safety and tolerability of roginolisib when administered in combination with ruxolit…
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Triple threat vaccine aims to shield seniors from three winter viruses
⭐️ VACCINE ⭐️ OngoingThis study is being done to find out how safe and effective a new combined vaccine candidate, called VXB-251, is for older adults. The vaccine candidate is designed to protect against three common viruses that can cause respiratory tract infections: * RSV (respiratory syncytial …
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
Could a nerve-stimulation device help the brain learn again after a stroke?
Knowledge-focused ENROLLING_BY_INVITATIONThe purpose of this study is to find out whether pairing vagus nerve stimulation (VNS) with cognitive training can improve memory and language learning in people who have previously used VNS therapy for movement rehabilitation after a stroke. VNS has been previously used to suppo…
Phase: NA • Sponsor: Stony Brook University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Immunotherapy after Chemo-Radiation shows promise for lung cancer
Disease control Recruiting nowThis prospective, multicentre, observational study aims to assess the effectiveness and safety of durvalumab as consolidation treatment for patients with LS-SCLC who have not progressed following CRT in real-world setting.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New light on colon polyps: can special imaging boost detection?
Disease control Recruiting nowThe goal of this clinical trial is to compare the detection rate of clinically significant serrated lesions (CSSL) in participants undergoing water exchange (WE) colonoscopy with artificial intelligence (AI)-based computer-aided detection (CADe) for screening, surveillance, diagn…
Phase: NA • Sponsor: Evergreen General Hospital, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
MRNA therapy takes on rare hormone disorder
Disease control Recruiting nowXH-02 is an mRNA nucleic acid drug that expresses PTH in the body following intravenous or subcutaneous injection, providing PTH replacement therapy for patients with hypoparathyroidism. Animal studies have shown pharmacodynamic effects of XH-02, with a favorable safety profile. …
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study tests Stoma-Free option for rectal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if somatostatin plus a clear liquid diet can help prevent severe leakage after rectal cancer surgery in adults with low or mid rectal cancer who are scheduled to have ultra-low anterior resection. These patients have a higher risk of le…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a High-Fat diet help cancer immunotherapy work better?
Disease control TerminatedThis phase I trial studies how well a ketogenic dietary intervention works to improve response to immunotherapy in patients with melanoma and kidney cancer that has spread from where it first started (primary site) to other places in the body (metastatic). A ketogenic diet (KD) m…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New online group therapy aims to clear chemo brain in breast cancer survivors
Symptom relief Recruiting nowThe goal of this clinical trial is to examine the efficacy of a novel, remotely-applied group intervention, Cognitive Retraining and Functional Treatment Group (CRAFT-G), designed to improve cognitive function, mental health and functional outcome in breast cancer survivors (BCS)…
Phase: NA • Sponsor: Hadassah Medical Organization • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a diabetes drug slow MS disability? new study investigates.
Disease control Recruiting nowThe primary outcome measure is PIRA (progression independent of relapse activity), based primarily on clinical assessment, dichotomized as present or not. For Aim 1, the cohort, patient-derived disability status (PDDS) score, and ambulation score (self-reported) will be the prim…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can amino acid supplements help reverse muscle wasting in liver disease patients?
Disease control Recruiting nowCirrhosis is a major global cause of morbidity and mortality in chronic liver disease patients, accounting for 2.4% of global deaths in 2019. A 1990-2017 Global Burden of Disease study showed rising cirrhosis-related deaths, bringing heavy health and economic burdens. It often le…
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Promising cocktail aims to shrink tonsil tumors before surgery
Disease control Recruiting nowThis is a prospective,single-arm,Phase II clinical study to designed to evaluate the efficancy and safety of nimotuzumab Combined with Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC